Alnylam Pharmaceuticals (ALNY) Revenue US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Revenue, bln rub ? 219.8 492.9 844.3 1 037 1 828   2 014  
Changes by years, y/y, % +193% +124% +71% +23% +76%     +89.5%

Alnylam Pharmaceuticals. Revenue US GAAP, bln rub

Alnylam Pharmaceuticals. Revenue US GAAP, changes, %

Alnylam Pharmaceuticals. Revenue US GAAP, sum by quarters, bln rub

Alnylam Pharmaceuticals (ALNY) Revenue US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Revenue, bln rub ? 750.5 439.7 494.3 659.8 420.1   2 014
Changes by years, y/y, % +184% +31% +55% +107% -44%    
Changes by quarters, q/q, % +135% -41% +12% +33% -36%    

Alnylam Pharmaceuticals. Revenue US GAAP, bln rub

Alnylam Pharmaceuticals. Revenue US GAAP, changes, y/y, %

Alnylam Pharmaceuticals. Revenue US GAAP, changes, q/q, %